Overexpression of antiapoptotic Bcl-2 or Bcl-xL probably occurs in more than half of all cancers [34], rendering tumor cells resistant to myriad apoptotic stimuli, including most cytotoxic anticancer drugs. This evidence concerns the gene BCL2L1 and cancer.